Detection of SS18-SSX1/2 fusion transcripts in circulating tumor cells of patients with synovial sarcoma

Abstract

Abstract A recent study on 15 patients with synovial sarcoma demonstrated very low prevalence of tumor-specific fusion transcripts in peripheral blood specimens. Our results in an independent cohort of 38 patients with synovial sarcoma support these findings. Synovial sarcoma patients could greatly benefit from a non-invasive monitoring of tumor burden by liquid biopsies. However, given the low detection rate of SS18-SSX1/2 in circulation, we conclude that alternative markers other than the tumor-type specific fusion transcripts should be considered.

Keywords

• Liquid biopsy
• Circulating tumor cells (CTCs)
• Nested RT-PCR
• SS18-SSX fusion transcript
• Synovial sarcoma